var eventsData = [{"Ticker":"TMO","EffectiveDate":"2017-01-31","Type":"EarningsBeatRevenueMiss","Title":"Before market open, TMO reports 2016 Q4's earning $2.41 per share and revenue $4953MM. This beats analyst's estimated EPS $2.39, misses estimated revenue $5000MM.","DailyReturn":"6.35%","FiveDayReturnAfter":"5.95%","FiveDayReturnBefore":"0.34%"},{"Ticker":"TMO","EffectiveDate":"2017-01-18","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on TMO to Buy. Target Price is $163.","DailyReturn":"-0.26%","FiveDayReturnAfter":"-2.84%","FiveDayReturnBefore":"-1.66%"},{"Ticker":"TMO","EffectiveDate":"2017-01-17","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on TMO to Buy. Target Price is $163.","DailyReturn":"-0.84%","FiveDayReturnAfter":"-2.42%","FiveDayReturnBefore":"-0.66%"},{"Ticker":"TMO","EffectiveDate":"2016-12-13","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"0.59%","FiveDayReturnAfter":"-2.64%","FiveDayReturnBefore":"2.65%"},{"Ticker":"TMO","EffectiveDate":"2016-11-10","Type":"RatingNeutral","Title":"Leerink Swann assumes TMO to Outperform.","DailyReturn":"1.51%","FiveDayReturnAfter":"-1.69%","FiveDayReturnBefore":"4.19%"},{"Ticker":"TMO","EffectiveDate":"2016-10-27","Type":"EarningsRevenueBeat","Title":"Before market open, TMO reports 2016 Q3's earning $2.03 per share and revenue $4491MM. This beats analyst's estimated EPS $1.98, beats estimated revenue $4380MM.","DailyReturn":"0.79%","FiveDayReturnAfter":"-1.52%","FiveDayReturnBefore":"-2.5%"},{"Ticker":"TMO","EffectiveDate":"2016-09-22","Type":"RatingNeutral","Title":"JP Morgan assumes TMO to Overweight.","DailyReturn":"1.44%","FiveDayReturnAfter":"2.05%","FiveDayReturnBefore":"4.99%"},{"Ticker":"TMO","EffectiveDate":"2016-09-21","Type":"RatingNeutral","Title":"UBS maintains TMO to Buy. Target Price is $176; previously $170.","DailyReturn":"2.5%","FiveDayReturnAfter":"4.67%","FiveDayReturnBefore":"4.36%"},{"Ticker":"TMO","EffectiveDate":"2016-09-13","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.75%","FiveDayReturnAfter":"2.53%","FiveDayReturnBefore":"-3.21%"},{"Ticker":"TMO","EffectiveDate":"2016-09-09","Type":"RatingNeutral","Title":"Cleveland Research downgrades TMO to Neutral from Buy.","DailyReturn":"-4.62%","FiveDayReturnAfter":"-0.32%","FiveDayReturnBefore":"-1.01%"},{"Ticker":"TMO","EffectiveDate":"2016-07-29","Type":"RatingNeutral","Title":"Citigroup maintains TMO to Buy. Target Price is $182; previously $160.","DailyReturn":"0.01%","FiveDayReturnAfter":"-1.52%","FiveDayReturnBefore":"1.66%"},{"Ticker":"TMO","EffectiveDate":"2016-07-28","Type":"EarningsRevenueBeat","Title":"Before market open, TMO reports 2016 Q2's earning $2.03 per share and revenue $4535MM. This beats analyst's estimated EPS $2.01, beats estimated revenue $4500MM.","DailyReturn":"-0.05%","FiveDayReturnAfter":"-1.84%","FiveDayReturnBefore":"0.76%"},{"Ticker":"TMO","EffectiveDate":"2016-07-22","Type":"RatingNeutral","Title":"BTIG Research assumes TMO to Buy. Target Price is $180.","DailyReturn":"0.44%","FiveDayReturnAfter":"1.66%","FiveDayReturnBefore":"-0.97%"},{"Ticker":"TMO","EffectiveDate":"2016-07-19","Type":"RatingNeutral","Title":"Barclays maintains TMO to Overweight. Target Price is $175; previously $170.","DailyReturn":"-0.26%","FiveDayReturnAfter":"-0.04%","FiveDayReturnBefore":"3.04%"},{"Ticker":"TMO","EffectiveDate":"2016-06-13","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.74%","FiveDayReturnAfter":"-3.63%","FiveDayReturnBefore":"-0.7%"},{"Ticker":"TMO","EffectiveDate":"2016-04-29","Type":"RatingNeutral","Title":"Jefferies downgrades TMO to Hold from Buy.","DailyReturn":"-0.73%","FiveDayReturnAfter":"-0.12%","FiveDayReturnBefore":"-1.38%"},{"Ticker":"TMO","EffectiveDate":"2016-04-28","Type":"EarningsRevenueBeat","Title":"Before market open, TMO reports 2016 Q1's earning $1.8 per share and revenue $4295MM. This beats analyst's estimated EPS $1.74, beats estimated revenue $4110MM.","DailyReturn":"-1.23%","FiveDayReturnAfter":"-1.77%","FiveDayReturnBefore":"0.47%"},{"Ticker":"TMO","EffectiveDate":"2016-03-11","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"1.74%","FiveDayReturnAfter":"0.31%","FiveDayReturnBefore":"-0.51%"},{"Ticker":"TMO","EffectiveDate":"2016-01-06","Type":"RatingNeutral","Title":"Avondale Partners initiates coverage on TMO to Market Outperform. Target Price is $168.","DailyReturn":"-0.76%","FiveDayReturnAfter":"-1.11%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"TMO","EffectiveDate":"2016-01-06","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on TMO to Buy.","DailyReturn":"-0.76%","FiveDayReturnAfter":"-1.11%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"TMO","EffectiveDate":"2015-12-11","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.57%","FiveDayReturnAfter":"2.32%","FiveDayReturnBefore":"1.91%"},{"Ticker":"TMO","EffectiveDate":"2015-09-11","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"0.83%","FiveDayReturnAfter":"5.07%","FiveDayReturnBefore":"-0.61%"},{"Ticker":"TMO","EffectiveDate":"2015-07-23","Type":"RatingNeutral","Title":"Leerink Swann maintains TMO to Outperform. Target Price is $149; previously $141.","DailyReturn":"0.38%","FiveDayReturnAfter":"-0.31%","FiveDayReturnBefore":"3.49%"},{"Ticker":"TMO","EffectiveDate":"2015-07-23","Type":"RatingNeutral","Title":"Baird maintains TMO to Outperform. Target Price is $160; previously $148.","DailyReturn":"0.38%","FiveDayReturnAfter":"-0.31%","FiveDayReturnBefore":"3.49%"},{"Ticker":"TMO","EffectiveDate":"2015-06-11","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"0.37%","FiveDayReturnAfter":"-1.07%","FiveDayReturnBefore":"0.15%"},{"Ticker":"TMO","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $155; previously $150.","DailyReturn":"0.62%","FiveDayReturnAfter":"-1.44%","FiveDayReturnBefore":"1.65%"},{"Ticker":"TMO","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"JP Morgan maintains TMO to Overweight. Target Price is $150; previously $145.","DailyReturn":"0.62%","FiveDayReturnAfter":"-1.44%","FiveDayReturnBefore":"1.65%"},{"Ticker":"TMO","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Barclays maintains TMO to Overweight. Target Price is $165; previously $160.","DailyReturn":"0.62%","FiveDayReturnAfter":"-1.44%","FiveDayReturnBefore":"1.65%"},{"Ticker":"TMO","EffectiveDate":"2015-03-12","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"0.63%","FiveDayReturnAfter":"4.66%","FiveDayReturnBefore":"-0.73%"},{"Ticker":"TMO","EffectiveDate":"2015-03-10","Type":"RatingNeutral","Title":"UBS initiates coverage on TMO to Buy.","DailyReturn":"-0.83%","FiveDayReturnAfter":"3.84%","FiveDayReturnBefore":"-2.5%"},{"Ticker":"TMO","EffectiveDate":"2014-12-11","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.36%","FiveDayReturnAfter":"-1.91%","FiveDayReturnBefore":"-1.24%"},{"Ticker":"TMO","EffectiveDate":"2014-10-23","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains TMO to Buy. Target Price is $140; previously $150.","DailyReturn":"2.1%","FiveDayReturnAfter":"1.96%","FiveDayReturnBefore":"2.39%"},{"Ticker":"TMO","EffectiveDate":"2014-10-03","Type":"RatingNeutral","Title":"BTIG Research initiates coverage on TMO to Neutral.","DailyReturn":"1.87%","FiveDayReturnAfter":"-1.13%","FiveDayReturnBefore":"-1.52%"},{"Ticker":"TMO","EffectiveDate":"2014-09-11","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.12%","FiveDayReturnAfter":"0.11%","FiveDayReturnBefore":"-0.11%"},{"Ticker":"TMO","EffectiveDate":"2014-09-08","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on TMO to Overweight. Target Price is $146.","DailyReturn":"0.28%","FiveDayReturnAfter":"-0.96%","FiveDayReturnBefore":"3.72%"},{"Ticker":"TMO","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on TMO to Buy. Target Price is $150.","DailyReturn":"-0.73%","FiveDayReturnAfter":"0.93%","FiveDayReturnBefore":"-0.37%"},{"Ticker":"TMO","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"Macquarie maintains TMO to Outperform. Target Price is $135; previously $130.","DailyReturn":"1.21%","FiveDayReturnAfter":"0.57%","FiveDayReturnBefore":"3.93%"},{"Ticker":"TMO","EffectiveDate":"2014-06-12","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.17%","FiveDayReturnAfter":"-0.13%","FiveDayReturnBefore":"2.04%"},{"Ticker":"TMO","EffectiveDate":"2014-03-21","Type":"RatingNeutral","Title":"Bank of America maintains TMO to Buy. Target Price is $142; previously $128.","DailyReturn":"-0.55%","FiveDayReturnAfter":"-4.9%","FiveDayReturnBefore":"0.26%"},{"Ticker":"TMO","EffectiveDate":"2014-03-13","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-2.44%","FiveDayReturnAfter":"-2.9%","FiveDayReturnBefore":"0.45%"},{"Ticker":"TMO","EffectiveDate":"2014-02-20","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades TMO to Buy from Neutral. Target Price is $153; previously $114.","DailyReturn":"2.38%","FiveDayReturnAfter":"2%","FiveDayReturnBefore":"0.66%"},{"Ticker":"TMO","EffectiveDate":"2014-02-11","Type":"RatingNeutral","Title":"JP Morgan assumes TMO to Overweight. Target Price is $135.","DailyReturn":"2.01%","FiveDayReturnAfter":"4.08%","FiveDayReturnBefore":"4.73%"},{"Ticker":"TMO","EffectiveDate":"2014-01-31","Type":"RatingNeutral","Title":"Morgan Stanley maintains TMO to Overweight. Target Price is $140; previously $128.","DailyReturn":"0.13%","FiveDayReturnAfter":"-0.48%","FiveDayReturnBefore":"1.91%"},{"Ticker":"TMO","EffectiveDate":"2014-01-06","Type":"RatingNeutral","Title":"Morgan Stanley maintains TMO to Overweight. Target Price is $128; previously $119.","DailyReturn":"0%","FiveDayReturnAfter":"3.92%","FiveDayReturnBefore":"-0.19%"},{"Ticker":"TMO","EffectiveDate":"2013-12-12","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.81%","FiveDayReturnAfter":"5.17%","FiveDayReturnBefore":"0.97%"},{"Ticker":"TMO","EffectiveDate":"2013-12-12","Type":"RatingNeutral","Title":"Bank of America maintains TMO to Buy. Target Price is $113; previously $110.","DailyReturn":"-0.81%","FiveDayReturnAfter":"5.17%","FiveDayReturnBefore":"0.97%"},{"Ticker":"TMO","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $110; previously $102.","DailyReturn":"-0.46%","FiveDayReturnAfter":"0.01%","FiveDayReturnBefore":"4.15%"},{"Ticker":"TMO","EffectiveDate":"2013-09-12","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"0.46%","FiveDayReturnAfter":"3.89%","FiveDayReturnBefore":"-0.05%"},{"Ticker":"TMO","EffectiveDate":"2013-08-15","Type":"RatingNeutral","Title":"Janney Capital initiates coverage on TMO to Buy. Target Price is $113.","DailyReturn":"-0.82%","FiveDayReturnAfter":"-2.18%","FiveDayReturnBefore":"0.41%"},{"Ticker":"TMO","EffectiveDate":"2013-07-24","Type":"EarningsRevenueBeat","Title":"Before market open, TMO reports 2013 Q2's earning $1.32 per share and revenue $3240MM. This beats analyst's estimated EPS $1.3, beats estimated revenue $3220MM.","DailyReturn":"1.21%","FiveDayReturnAfter":"1.06%","FiveDayReturnBefore":"2.21%"},{"Ticker":"TMO","EffectiveDate":"2013-06-13","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"1.36%","FiveDayReturnAfter":"0.58%","FiveDayReturnBefore":"-2.16%"},{"Ticker":"TMO","EffectiveDate":"2013-04-24","Type":"EarningsRevenueBeat","Title":"Before market open, TMO reports 2013 Q1's earning $1.37 per share and revenue $3190MM. This beats analyst's estimated EPS $1.29, beats estimated revenue $3180MM.","DailyReturn":"0.69%","FiveDayReturnAfter":"0.04%","FiveDayReturnBefore":"-1.45%"},{"Ticker":"TMO","EffectiveDate":"2013-04-17","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $95; previously $80.","DailyReturn":"-0.39%","FiveDayReturnAfter":"-1.45%","FiveDayReturnBefore":"4.29%"},{"Ticker":"TMO","EffectiveDate":"2013-04-16","Type":"RatingNeutral","Title":"Credit Suisse maintains TMO to Outperform. Target Price is $89; previously $79.","DailyReturn":"4.12%","FiveDayReturnAfter":"1.72%","FiveDayReturnBefore":"0.3%"},{"Ticker":"TMO","EffectiveDate":"2013-04-04","Type":"RatingNeutral","Title":"UBS maintains TMO to Buy. Target Price is $87; previously $79.","DailyReturn":"-0.23%","FiveDayReturnAfter":"4.06%","FiveDayReturnBefore":"4.18%"},{"Ticker":"TMO","EffectiveDate":"2013-03-13","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"0.09%","FiveDayReturnAfter":"-0.18%","FiveDayReturnBefore":"1.64%"},{"Ticker":"TMO","EffectiveDate":"2013-02-14","Type":"RatingNeutral","Title":"Citigroup maintains TMO to Buy. Target Price is $82; previously $83.","DailyReturn":"-0.29%","FiveDayReturnAfter":"-4.09%","FiveDayReturnBefore":"1.7%"},{"Ticker":"TMO","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"UBS maintains TMO to Buy. Target Price is $82; previously $79.","DailyReturn":"3.65%","FiveDayReturnAfter":"2.28%","FiveDayReturnBefore":"3.35%"},{"Ticker":"TMO","EffectiveDate":"2013-02-01","Type":"RatingUpgrade","Title":"JP Morgan upgrades TMO to Overweight from Neutral. Target Price is $80; previously $70.","DailyReturn":"3.65%","FiveDayReturnAfter":"2.28%","FiveDayReturnBefore":"3.35%"},{"Ticker":"TMO","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Credit Suisse maintains TMO to Outperform. Target Price is $79; previously $71.","DailyReturn":"3.65%","FiveDayReturnAfter":"2.28%","FiveDayReturnBefore":"3.35%"},{"Ticker":"TMO","EffectiveDate":"2013-02-01","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $80; previously $66.","DailyReturn":"3.65%","FiveDayReturnAfter":"2.28%","FiveDayReturnBefore":"3.35%"},{"Ticker":"TMO","EffectiveDate":"2013-01-31","Type":"EarningsRevenueBeat","Title":"Before market open, TMO reports 2012 Q4's earning $1.36 per share and revenue $3260MM. This beats analyst's estimated EPS $1.28, beats estimated revenue $3130MM.","DailyReturn":"2.48%","FiveDayReturnAfter":"4.77%","FiveDayReturnBefore":"0.84%"},{"Ticker":"TMO","EffectiveDate":"2013-01-31","Type":"RatingNeutral","Title":"ISI Group maintains TMO to Buy. Target Price is $81; previously $73.5.","DailyReturn":"2.48%","FiveDayReturnAfter":"4.77%","FiveDayReturnBefore":"0.84%"},{"Ticker":"TMO","EffectiveDate":"2013-01-31","Type":"RatingNeutral","Title":"Bank of America maintains TMO to Buy. Target Price is $82; previously $70.","DailyReturn":"2.48%","FiveDayReturnAfter":"4.77%","FiveDayReturnBefore":"0.84%"},{"Ticker":"TMO","EffectiveDate":"2013-01-31","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $80; previously $66.","DailyReturn":"2.48%","FiveDayReturnAfter":"4.77%","FiveDayReturnBefore":"0.84%"},{"Ticker":"TMO","EffectiveDate":"2012-12-13","Type":"Dividend","Title":"The Firm pays dividend $0.15","DailyReturn":"-0.12%","FiveDayReturnAfter":"-0.38%","FiveDayReturnBefore":"1.84%"},{"Ticker":"TMO","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $66; previously $64.","DailyReturn":"2.22%","FiveDayReturnAfter":"1.87%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"TMO","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Credit Suisse maintains TMO to Outperform. Target Price is $71; previously $65.","DailyReturn":"2.22%","FiveDayReturnAfter":"1.87%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"TMO","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"UBS maintains TMO to Buy. Target Price is $68; previously $64.","DailyReturn":"2.22%","FiveDayReturnAfter":"1.87%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"TMO","EffectiveDate":"2012-10-24","Type":"EarningsRevenueBeat","Title":"After market close, TMO reports 2012 Q3's earning $1.19 per share and revenue $3090MM. This beats analyst's estimated EPS $1.16, beats estimated revenue $2990MM.","DailyReturn":"4.77%","FiveDayReturnAfter":"8.03%","FiveDayReturnBefore":"-4.51%"},{"Ticker":"TMO","EffectiveDate":"2012-10-24","Type":"RatingNeutral","Title":"Goldman Sachs maintains TMO to Neutral. Target Price is $64; previously $60.","DailyReturn":"4.77%","FiveDayReturnAfter":"8.03%","FiveDayReturnBefore":"-4.51%"},{"Ticker":"TMO","EffectiveDate":"2012-10-24","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $66; previously $64.","DailyReturn":"4.77%","FiveDayReturnAfter":"8.03%","FiveDayReturnBefore":"-4.51%"},{"Ticker":"TMO","EffectiveDate":"2012-10-24","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains TMO to Buy. Target Price is $68; previously $65.","DailyReturn":"4.77%","FiveDayReturnAfter":"8.03%","FiveDayReturnBefore":"-4.51%"},{"Ticker":"TMO","EffectiveDate":"2012-10-24","Type":"RatingNeutral","Title":"JP Morgan maintains TMO to Neutral. Target Price is $68; previously $67.","DailyReturn":"4.77%","FiveDayReturnAfter":"8.03%","FiveDayReturnBefore":"-4.51%"},{"Ticker":"TMO","EffectiveDate":"2012-10-24","Type":"RatingNeutral","Title":"ISI Group maintains TMO to Overweight. Target Price is $71; previously $67.","DailyReturn":"4.77%","FiveDayReturnAfter":"8.03%","FiveDayReturnBefore":"-4.51%"},{"Ticker":"TMO","EffectiveDate":"2012-10-05","Type":"RatingUpgrade","Title":"Wells Fargo upgrades TMO to Outperform.","DailyReturn":"0.99%","FiveDayReturnAfter":"-1.89%","FiveDayReturnBefore":"1.43%"},{"Ticker":"TMO","EffectiveDate":"2012-09-13","Type":"Dividend","Title":"The Firm pays dividend $0.13","DailyReturn":"1.3%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"3.93%"},{"Ticker":"TMO","EffectiveDate":"2012-08-09","Type":"RatingNeutral","Title":"Wallachbeth initiates coverage on TMO to Buy.","DailyReturn":"-0.61%","FiveDayReturnAfter":"0.45%","FiveDayReturnBefore":"2.9%"},{"Ticker":"TMO","EffectiveDate":"2012-07-26","Type":"RatingNeutral","Title":"Jefferies maintains TMO to Buy. Target Price is $64; previously $63.","DailyReturn":"1.01%","FiveDayReturnAfter":"2.76%","FiveDayReturnBefore":"1.69%"},{"Ticker":"TMO","EffectiveDate":"2012-07-25","Type":"EarningsRevenueBeat","Title":"Before market open, TMO reports 2012 Q2's earning $1.22 per share and revenue $3110MM. This beats analyst's estimated EPS $1.16, beats estimated revenue $3050MM.","DailyReturn":"8.75%","FiveDayReturnAfter":"11.18%","FiveDayReturnBefore":"-4.97%"},{"Ticker":"TMO","EffectiveDate":"2012-07-25","Type":"RatingNeutral","Title":"ISI Group maintains TMO to Overweight. Target Price is $61.5; previously $61.","DailyReturn":"8.75%","FiveDayReturnAfter":"11.18%","FiveDayReturnBefore":"-4.97%"},{"Ticker":"TMO","EffectiveDate":"2012-07-23","Type":"RatingNeutral","Title":"Barclays maintains TMO to Overweight. Target Price is $60; previously $58.","DailyReturn":"-2.59%","FiveDayReturnAfter":"7.49%","FiveDayReturnBefore":"0.01%"},{"Ticker":"TMO","EffectiveDate":"2012-07-16","Type":"RatingNeutral","Title":"JP Morgan terminates TMO coverage .","DailyReturn":"-0.26%","FiveDayReturnAfter":"0.01%","FiveDayReturnBefore":"1.17%"},{"Ticker":"TMO","EffectiveDate":"2012-07-10","Type":"RatingNeutral","Title":"ISI Group initiates coverage on TMO to Overweight. Target Price is $60.","DailyReturn":"-0.77%","FiveDayReturnAfter":"0.61%","FiveDayReturnBefore":"-0.63%"},{"Ticker":"TMO","EffectiveDate":"2012-06-13","Type":"Dividend","Title":"The Firm pays dividend $0.13","DailyReturn":"-0.63%","FiveDayReturnAfter":"3.4%","FiveDayReturnBefore":"1.86%"},{"Ticker":"TMO","EffectiveDate":"2012-05-15","Type":"RatingNeutral","Title":"Mizuho downgrades TMO to Neutral from Buy. Target Price is $55; previously $65.","DailyReturn":"-1.35%","FiveDayReturnAfter":"-1.18%","FiveDayReturnBefore":"-2.79%"},{"Ticker":"TMO","EffectiveDate":"2012-04-26","Type":"RatingNeutral","Title":"UBS maintains TMO to Buy. Target Price is $64; previously $62.","DailyReturn":"-0.29%","FiveDayReturnAfter":"0.97%","FiveDayReturnBefore":"1%"},{"Ticker":"TMO","EffectiveDate":"2012-04-25","Type":"RatingNeutral","Title":"JP Morgan maintains TMO to Neutral. Target Price is $57; previously $55.","DailyReturn":"4.41%","FiveDayReturnAfter":"6.19%","FiveDayReturnBefore":"-2.5%"},{"Ticker":"TMO","EffectiveDate":"2012-03-13","Type":"Dividend","Title":"The Firm pays dividend $0.13","DailyReturn":"3.29%","FiveDayReturnAfter":"4.71%","FiveDayReturnBefore":"-2.09%"},{"Ticker":"TMO","EffectiveDate":"2012-03-06","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on TMO to Overweight. Target Price is $66.","DailyReturn":"-1.99%","FiveDayReturnAfter":"-2.09%","FiveDayReturnBefore":"0.23%"}];